Evidence map›Paper›PMID 19270527›Full record

ReviewCell cycle (Georgetown, Tex.)2009

Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives.

G-One Ahn, J Martin Brown

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanical regulation of signal transduction in angiogenesis.Frontiers in cell and developmental biology · 2022
    Review
  4. Celecoxib Blocks Vasculogenic MimicryFrontiers in oncology · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

G-One AhnDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford, California, USA.
J Martin Brown
Russian State Agrarian Correspondence University · RU

Funding

Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth CancersR01CA128873 · NCI · STANFORD UNIVERSITY · PI BROWN, JOHN MARTIN · 2008 to 2012
$2.5M
Experimental Radiotherapy and Chemotherapy With a Potent New Hypoxic CytotoxinR01CA118202 · NCI · STANFORD UNIVERSITY · PI BROWN, JOHN MARTIN · 2006 to 2010
$1.4M
NCI NIH HHS CA118202NCI NIH HHS CA128873NCI NIH HHS R01 CA118202NCI NIH HHS R01 CA128873
6 · The paper itself

Abstract

In this review, we highlight some of recent studies underscoring the importance of the tumor microenvironment, especially the role of bone marrow-derived myeloid cells, in restoring tumor growth after irradiation. Myeloid cells are hematopoietic cells that give rise to monocytes and macrophages in the peripheral blood and tissues. These cells have been shown to be proangiogenic in tumors promoting tumor growth. We also discuss our previously unpublished results on the effect of irradiation on the tumor vasculature including pericyte and basement membrane coverage to the endothelium of tumor blood vessels. We summarize the clinical significance of these studies including the use of MMP-9 inhibitors, administering white blood cell boosters, or planning safety margin of tumor volumes, in order to improve overall clinical benefits in cancer patients treated with radiotherapy.

Indexed as

AnimalsDisease Models, AnimalEnzyme InhibitorsHumansMacrophagesMatrix Metalloproteinase InhibitorsMonocytesMyeloid CellsNeoplasmsNeovascularization, PathologicVascular Endothelial Growth Factor AWhole-Body IrradiationEnzyme InhibitorsMatrix Metalloproteinase InhibitorsVascular Endothelial Growth Factor A

Identifiers

PMID19270527
PMCPMC2862685
OpenAlexW2122455505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.